Low preoperative hepcidin concentration is a risk factor for mortality but not for acute kidney injury after cardiac surgery

por Haase-Fieiltz, A, Mertens, P, Plaß, M, Westerman, M, Bellomo, R, Haase, M
Publicado 2012

Quality specifications in postgraduate medical e-learning: an integrative literature review leading to a postgraduate medical e-learning model

por De Leeuw, R. A., Westerman, M., Nelson, E., Ket, J. C. F., Scheele, F.
Publicado 2016

Sex chromosome and autosome divergence in Podisma (Orthoptera) in western Europe

por Bella, JL, Westerman, M, López-Fernández, C, de la Torre, J, Rubio, JM, Gosálvez, J
Publicado 1991

Survey into bereavement of family members of patients who died in the intensive care unit

por Heijboer, L, Klink, J Van der, Hofhuis, J, Hovingh, A, Rommes, J, Westerman, M, Spronk, P
Publicado 2010

Urinary hepcidin is potentially a marker of systemic infection rather than inflammation, in the setting of preserved renal function

por Glassford, NJ, Schneider, AG, Eastwood, G, Peck, L, Young, H, Westerman, M, Ostland, V, Bellomo, R
Publicado 2011

Renal biomarkers are less useful at predicting acute kidney injury in patients with sepsis than those without

por Glassford, N, Schneider, A, Eastwood, G, Peck, L, Young, H, Westerman, M, Ostland, V, Bellomo, R
Publicado 2011

Tools for a systematic appraisal of integrated community-based approaches to prevent childhood obesity

por Mantziki, K., Renders, C. M., Westerman, M. J., Mayer, J., Borys, J. M., Seidell, J. C.
Publicado 2018

A qualitative study of the anticipated barriers and facilitators to the implementation of a lifestyle intervention in the dutch construction industry

por Tonnon, S C, Proper, K I, van der Ploeg, H P, Westerman, M J, Sijbesma, E, van der Beek, A J
Publicado 2014

Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule

por Boven, E, Westerman, M, van Groeningen, C J, Verschraagen, M, Ruijter, R, Zegers, I, van der Vijgh, W J F, Giaccone, G
Publicado 2005

COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study

por Terwee, C. B., Prinsen, C. A. C., Chiarotto, A., Westerman, M. J., Patrick, D. L., Alonso, J., Bouter, L. M., de Vet, H. C. W., Mokkink, L. B.
Publicado 2018

P53 REAL-WORLD TREATMENT SEQUENCES AND COSTS OF 96 PATIENTS WITH MULTIPLE MYELOMA FROM DIAGNOSIS TO DEATH

por Seefat, M.R., Cucchi, D.G.J., Groen, K., Donker, M.L., van der Hem, K.G., Westerman, M., Gerrits, A.M., Beeker, A., van de Donk, N., Blommestein, H.M., Zweegman, S.
Publicado 2023

Development of the Patient Scale of the Patient and Observer Scar Assessment Scale (POSAS) 3.0: a qualitative study

por Carrière, M. E., Mokkink, L. B., Tyack, Z., Westerman, M. J., Pijpe, A., Pleat, J., van de Kar, A. L., Brown, J., de Vet, H. C. W., van Zuijlen, P. P. M.
Publicado 2022

Perceptions of Dutch health care professionals on weight gain during chemotherapy in women with breast cancer

por de Kruif, J. Th. C. M., Scholtens, M. B., van der Rijt, J., de Boer, M. R., van den Berg, M. M. G. A., de Vries, Y. C., Winkels, R. M., Visser, M., Kampman, E., Westerman, M. J.
Publicado 2018

A longitudinal mixed methods study on changes in body weight, body composition, and lifestyle in breast cancer patients during chemotherapy and in a comparison group of women witho...

por de Kruif, J. Th. C. M., Visser, M., van den Berg, M. M. G. A., Derks, M. J. M., de Boer, M. R., van Laarhoven, H. W. M., de Vries, J. H. M., de Vries, Y. C., Kampman, E., Winkels, R. W., Westerman, M. J.
Publicado 2019

Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study

por Luijten, J. C. H. B. M., Vissers, P. A. J., Brom, L., de Bièvre, M., Buijsen, J., Rozema, T., Mohammad, N. Haj, van Duijvendijk, P., Kouwenhoven, E. A., Eshuis, W. J., Rosman, C., Siersema, P. D., van Laarhoven, H. W. M., Verhoeven, R. H. A., Nieuwenhuijzen, G. A. P., Westerman, M. J.
Publicado 2022

P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE P...

por Groen, K., Stege, C., Nasserinejad, K., de Heer, K., van Kampen, R., Leys, R., Thielen, N., Westerman, M., Wu, K., Ludwig, I., Issa, D., Velders, G., Vekemans, M., van de Donk, N., Timmers, G., de Boer, F., Tick, L., van der Spek, E., de Waal, E., Sohne, M., Sonneveld, P., Nijhof, I., Klein, S., Levin, M., Ypma, P., Zweegman, S.
Publicado 2023

Team dynamics and clinician’s experience influence decision-making during Upper-GI multidisciplinary team meetings: A multiple case study

por Luijten, J.C.H.B.M., Westerman, M.J., Nieuwenhuijzen, G.A.P., Walraven, J.E.W., Sosef, M.N., Beerepoot, L.V., van Hillegersberg, R., Muller, K., Hoekstra, R., Bergman, J.J.G.H.M., Siersema, P.D., van Laarhoven, H.W.M., Rosman, C., Brom, L., Vissers, P.A.J., Verhoeven, R.H.A.
Publicado 2022

Cost-utility of an eHealth application ‘Oncokompas’ that supports cancer survivors in self-management: results of a randomised controlled trial

por van der Hout, A., Jansen, F., van Uden-Kraan, C. F., Coupé, V. M., Holtmaat, K., Nieuwenhuijzen, G. A., Hardillo, J. A., de Jong, R. J. Baatenburg, Tiren-Verbeet, N. L., Sommeijer, D. W., de Heer, K., Schaar, C. G., Sedee, R. J. E., Bosscha, K., van den Brekel, M. W. M., Petersen, J. F., Westerman, M., Honings, J., Takes, R. P., Houtenbos, I., van den Broek, W. T., de Bree, R., Jansen, P., Eerenstein, S. E. J., Leemans, C. R., Zijlstra, J. M., Cuijpers, P., van de Poll-Franse, L. V., Verdonck-de Leeuw, I. M.
Publicado 2020

Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled...

por van der Hout, A., van Uden-Kraan, C.F., Holtmaat, K., Jansen, F., Lissenberg-Witte, B.I., Nieuwenhuijzen, G.A.P., Hardillo, J.A., Baatenburg de Jong, R.J., Tiren-Verbeet, N.L., Sommeijer, D.W., de Heer, K., Schaar, C.G., Sedee, R.J.E., Bosscha, K., van den Brekel, M.W.M., Petersen, J.F., Westerman, M., Honings, J., Takes, R.P., Houtenbos, I., van den Broek, W.T., de Bree, R., Jansen, P., Eerenstein, S.E.J., Leemans, C.R., Zijlstra, J.M., Cuijpers, P., van de Poll-Franse, L.V., Verdonck-de Leeuw, I.M.
Publicado 2021

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV)

por Seefat, M.R., Stege, C.A.M., Timmers, G.J., Levin, M.D., Hoogendoorn, M., Ypma, P.F., Nijhof, I.S., Velders, G.A., Strobbe, L., Durdu-Rayman, N., Westerman, M., Davidis-van Schoonhoven, M.A., van Kampen, R.J.W., Beeker, A., Koster, A., Dijk, A.C., van de Donk, N.W.C.J., van der Spek, E., Leys, M.B.L., Silbermann, M.H., Groen, K., van der Burg-de Graauw, N.C.H.P., Sinnige, H.A.M., van der Hem, K.G., Levenga, T.H., Bilgin, Y.M., Sonneveld, P., Klein, S.K., Nasserinejad, K., Blommestein, H.M., Cucchi, D.G.J., Lissenberg-Witte, B.I., Zweegman, S.
Publicado 2023